Gender differences in self-reported social functioning of patients with chronic coronary artery disease and affective disorders

 Aim. To determine gender differences in self-reported social functioning of patients with comorbidity of affective disorders (ADs) and chronic coronary artery disease.

Materials and methods. Self-reported social functioning of 248 cardiological patients (194 men (78.2%) and 54 women (21.8%)) with chronic coronary artery disease (CAD) and ADs was studied using the Social Adaptation Self-evaluation Scale (SASS). The mean age of patients with chronic CAD in men was (57.2 ± 6.5) years, and in women (59.3 ± 7.1), p = 0.04. Qualitative and quantitative indicators were investigated using the Mann – Whitney, Wilcoxon and T-test; χ2 (Pearson›s goodness-of-fit test) was used to estimate the frequencies.

Results. ADs were represented by chronic mood disorders (45%), first-time depressive episodes (DEs) 24%, recurrent DEs 24.5%, as well as bipolar II disorder (BD II) 6.5%. ADs in 42.4% of patients were associated with psychosocial stressors (mainly, loss), p = 0.02. Men statistically significantly  more often (37.1%, 72/194) than women (16.7%, 9/54) communicated more scarcely with others as a result of projection mechanisms, a high level of hostility, passive aggressiveness and lack of initiative, typical for patients with ADs, p = 0.003.

Conclusion. The social functioning of patients with ADs and chronic coronary artery disease was complicated irrespective of gender. Women were single and bereaved of their children more often than men. Due to the low level of communication outside the family and outside of professional activity, most of the patients maintained communication mainly with the family. However, due to ADs, they were not able to feel support from family
members and rarely initiated communication with other people (men did it statistically significantly more often than women). 

1. Murphy B., Le Grande M., Alvarenga M., Worcester M., Jackson A. Anxiety and depression after a cardiac event: Prevalence and predictors. Frontiers in Psychology. 2020; 10: 3010. DOI: 10.3389/fpsyg.2019.03010.

2. Рощина О.В., Розин А.И., Счастный Е.Д., Бохан Н.А. Клиническое значение коморбидности аффективных расстройств и алкогольной зависимости. Бюллетень сибирской медицины. 2019; 18 (4): 110–118. DOI: 10.20538/1682-0363-2019-4-110–118.

3. Лебедева Е.В., Симуткин Г.Г., Счастный Е.Д., Репин А.Н., Сергиенко Т.Н. Особенности тревожно-депрессивных расстройств и суицидального поведения у пациентов старше 60 лет с хронической ишемической болезнью сердца. Суицидология. 2014; 5 (2): 69–76.

4. Васильева С.Н., Симуткин Г.Г., Счастный Е.Д., Иванова С.А., Бохан Н.А. Суицидальное поведение больных биполярным аффективным расстройством при коморбидных психических заболеваниях. Суицидология. 2018; 9 (3): 86–92. DOI: 10.32878/suiciderus.18-09-03(32)-86-92.

5. Дубровская В.В., Корнетова Е.Г., Меднова И.А., Дмитриева Е.Г., Лебедева Е.В., Корнетов А.Н., Семке А.В. Висцеральное ожирение у пациентов с шизофренией и сопутствующим метаболическим синдромом, получающих антипсихотическую терапию. Психическое здоровье. 2019; 12: 10–15. DOI: 10.25557/2074-014X.2019.12.10-15.

6. Mavrides N., Nemeroff C.B. Treatment of affective disorders in cardiac disease. Dialogues in Clinical Neuroscience. 2015; 17 (2): 127–140.

7. Lebedeva E.V., Schastnyy E.D., Simutkin G.G., Sergienko T.N., Nonka T.G., Repin A.N. EV0224 – Patients with mood disorders and chronic coronary artery disease receiving conservative therapy have a higher risk of death during affective episode. Abstracts of the 25th European Congress of Psychiatry. 1–4 April 2017, Florence, Italy. European Psychiatry. 2017; 41 (S1): 476. DOI: 10.1016/j.eurpsy.2017.01.554.

8. Smolderen K.G., Strait K.M., Dreyer R.P, D’Onofrio G., Zhou S., Lichtman J.H., Geda M., Bueno H., Beltrame J., Safdar B., Krumholz H.M., Spertus J.A. Depressive symptoms in younger women and men with acute myocardial infarction: insights from the VIRGO study. Journal of the American Heart Association. 2015; 4 (4): e001424. DOI: 10.1161/JAHA.114.001424.

9. Vaccarino V., Sullivan S., Hammadah M., Wilmot K., Al Mheid I., Ramadan R., Elon L., Pimple P.M., Garcia E.V., Nye J., Shah A.J., Alkhoder A., Levantsevych O., Gay H., Obideen M., Huang M., Lewis T.T., Bremner J.D., Quyyumi A.A., Raggi P. Mental stress-induced-myocardial ischemia in young patients with recent myocardial infarction: sex differences and mechanisms. Circulation. 2018; 137 (8): 794–805. DOI: 10.1161/CIRCULATIONAHA.117.030849.

10. Cenko E., Yoon J., Kedev S., Stankovic G., Vasiljevic Z., Krljanac G., Kalpak O., Ricci B, Milicic D., Manfrini O., van der Schaar M., Badimon L., Bugiardini R. Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Internal Medicine. 2018; 178 (5): 632–639. DOI: 10.1001/jamainternmed.2018.0514.

11. Vaccarino V., Badimon L., Bremner J.D., Cenko E., Cubedo J., Dorobantu M., Duncker D.J., Koller A., Manfrini O., Milicic D., Padro T., Pries A.R., Quyyumi A.A., Tousoulis D., Trifunovic D., Vasiljevic Z., de Wit C., Bugiardini R.; ESC Scientific Document Group Reviewers. Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal. 2020; 41 (17): 1687–1696. DOI: 10.1093/eurheartj/ehy913.

12. Корнетов А.Н. Оценка депрессивных расстройств у больных, страдающих соматическими заболеваниями, в условиях первичной медицинской сети. Российский психиатрический журнал. 2007; 1: 37–41.

13. Лебедева Е.В., Счастный Е.Д., Симуткин Г.Г., Репин А.Н., Нонка Т.Г. Клиническая характеристика аффективных расстройств и эффективность антидепрессивной терапии у больных хронической ишемической болезнью сердца. Бюллетень сибирской медицины. 2018; 17 (4): 85–93. DOI: 10.20538/1682-0363-2018-4-85-93.

14. Лебедева Е.В., Сергиенко Т.Н., Нонка Т.Г., Счастный Е.Д., Симуткин Г.Г., Шишнева Е.В., Горохов А.С., Суровцева А.К., Перчаткин В.А., Репин А.Н. Психотерапевтические аспекты работы в практике врача-кардиолога при подготовке пациентов с ИБС к аортокоронарному шунтированию. Сибирский вестник психиатрии и наркологии. 2017; 2 (95): 81–90.

15. Segal Z.V., Dimidjian S., Beck A., Boggs J.M., Vanderkruik R., Metcalf C.A., Gallop R., Felder J.N., Levy J. Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2020; 77 (6): 563–573. DOI: 10.1001/jamapsychiatry.2019.4693.

16. Bullinger M., Möller H.J., Engel R.E., Hoff P. Lebensqualitat – ein Ziel – und Bewertungskriterium medizinischen Handelns? Befunderhebung in der Psychiatrie: Lebensqualität, Negativsymptomatik und andere aktuelle Entwicklungen. Berlin: Springer, 1996: 13–29.

17. Dekker R.L., Lennie T.A., Albert N.M., Rayens M.K., Chung M.L., Wu J.R., Song E.K., Moser D.K. Depressive symptom trajectory predicts 1-year health-related quality of life in patients with heart failure. Journal of Cardiac Failure. 2011; 17 (9): 755–763. DOI: 10.1016/j.cardfail.2011.04.016.

18. Суровцева А.К., Счастный Е.Д. Особенности субъективной оценки качества жизни пациентов аффективными расстройствами с различным риском суицидального поведения. Суицидология. 2014; 5 (4): 52–57.

19. Дорофеева Н.П., Иванченко Д.Н., Машталова О.Г., Куликова И.Е., Чибинева С.А., Орехова Ю.Н., Кияшко Е.Е., Радченко Е.Ю. Качество жизни у пациентов с ишемической болезнью сердца. Клиническая практика. 2017; 8 (1): 25–29. DOI: 10.17816/clinpract8125-29.